**Summary.** A survey of principal pharmacokinetic (PK) studies on factor VIII (FVIII) and factor IX (FIX) plasmaβ and rDNAβderived concentrates, analysed by means of the PKRD program, has been performed. Notwithstanding the accurate definition of the study design, released in 1991 by the Scientific
β¦ LIBER β¦
Standardization of assays of factor VIII and factor IX
β Scribed by Trevor W. Barrowcliffe
- Book ID
- 105639168
- Publisher
- Springer
- Year
- 1990
- Tongue
- English
- Weight
- 617 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0940-5437
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Pharmacokinetics of factor VIII and fact
β
M. Morfini
π
Article
π
2003
π
John Wiley and Sons
π
English
β 76 KB
Inhibitors of factor VIII and IX
β
DOREEN B. BRETTLER
π
Article
π
1995
π
John Wiley and Sons
π
English
β 463 KB
Prophylactic dosing of factor VIII and f
β
S. BjΓΆrkman
π
Article
π
2003
π
John Wiley and Sons
π
English
β 118 KB
**Summary.** The high cost and limited availability of factor concentrates make dosing of factor VIII (FVIII) or factor IX (FIX) a crucial issue in the prophylactic treatment of haemophilia. It has often been recommended that this treatment should aim to maintain a minimum plasma level of 1% of norm
Adherence to prophylactic infusions of f
β
C. D. THORNBURG; S. W. PIPE
π
Article
π
2006
π
John Wiley and Sons
π
English
β 55 KB
Pathogenic antibodies to coagulation fac
β
P. Lollar
π
Article
π
2004
π
John Wiley and Sons
π
English
β 228 KB
Genetic risk factors for inhibitors to f
β
J. OLDENBURG; A. PAVLOVA
π
Article
π
2006
π
John Wiley and Sons
π
English
β 588 KB